Compound Q&A
What are the main uses of Ponatinib (CAS: 943319-70-8)?
Answer
Ponatinib is primarily used in oncology, particularly for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). It is also being investigated for use in other cancers due to its broad kinase inhibitory activity.
About
CAS No
943319-70-8
English Name
Ponatinib
Molecular Formula
C29H27F3N6O
Molecular Weight
532.56 g/mol
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5
InChIKey
PHXJVRSECIGDHY-UHFFFAOYSA-N
Last Updated: 2025-08-25 01:08
